Earnings Call · Q1 FY2026·2026-05-14

Q1 26EPS +29.26%·Rev n/aQ4 25EPS +56.73%·Rev n/aQ3 25EPS +44.27%·Rev n/aQ2 25EPS +8.38%·Rev n/a⚠ consensus missing

Cellectar Biosciences, Inc. CLRB

Anne Marie Fields — Managing Director

James Caruso — Chief Executive Officer

Chad Kolean — Chief Financial Officer

Jarrod Longcor — Chief Operating Officer

+8.8%1d on move date+8.1% vs SPY3d+6.8%5d+7.8%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more CLRB calls or request research access.

More CLRB calls Browse calls Request research access